CCCC DCF Valuation - C4 Therapeutics Inc

Dashboard Market News Investing Ideas Pricing

Watchlist Manager

Watchlist

Price: 4.37 USD 19.4% Market Closed

Market Cap: $426.4m

	C4 Therapeutics Inc NASDAQ:CCCC	US
	Energy Transfer LP NYSE:ET	US
	Arcosa Inc NYSE:ACA	US
	REA Group Ltd ASX:REA	AU
	Kikkoman Corp TSE:2801	JP
C	Compass Inc NYSE:COMP	US
	WhiteHorse Finance Inc NASDAQ:WHF	US
A	ACG Acquisition Company Ltd LSE:ACG	VG
	Subsea 7 SA OSE:SUBC	UK
M	Mitsubishi Estate Logistics REIT Investment Corp TSE:3481	JP
B	Beforepay Group Ltd ASX:B4P	AU
	Darden Restaurants Inc NYSE:DRI	US
	Urban Edge Properties NYSE:UE	US
	Paris Miki Holdings Inc TSE:7455	JP
	Cleveland-Cliffs Inc NYSE:CLF	US
	Motorola Solutions Inc NYSE:MSI	US
	Reckitt Benckiser Group PLC LSE:RKT	UK

CCCC's DCF value cannot be reliably calculated.

Relative Valuation Wall Street Price Targets

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.